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The essence of nanotechnology is the production of nanoparticles (NPs) with unique physicochemical properties allowing
worldwide application in new structures, materials, and devices. The consequently increasing human exposure to NPs has raised
concerns regarding their health and safety profiles. Titanium dioxide (TiO2) has been reported to induce adverse pulmonary
responses in exposed animals. However, the potential more dangerous biological activities of TiO2 NPs compared to their fine-
sized counterparts are not fully understood. Therefore, this work is aimed to provide a comprehensive evaluation of the toxic effects
induced by TiO2 NPs in in vivo experiments. It is intended to deeply understand the toxicological behaviour of TiO2 NPs and to
predict potential human health effects. Moreover, it may be an instrument to extrapolate relevant data for human risk evaluation
andmanagement and to identify those critical aspects that deserve great attention in future population and epidemiologic research.
1. Introduction
Nanotechnology is the manipulation of matter on a near-
atomic scale to produce new structures, materials, and
devises. It has became an important industry in the twenty-
first century, and the U.S. National Science Foundation esti-
mated it will grow into a trillion-dollar business, employing
millions of workers worldwide, within the next decade [1–3].
The essence of nanotechnology is the synthesis of
engineered nanoparticles (NPs) that exhibit characteris-
tics, such as small size, large surface area to mass ratio,
shape, crystallinity, surface charge, reactive surface groups,
dissolution rate, state of agglomeration, or dispersal that
confer them properties substantially different from those of
the bulk particles of the same composition [4–6]. These
properties offer great opportunities for the development of
new NP industrial applications increasing their worldwide
distribution and enhancing the likelihood of environmental
and human exposure [5, 7].
Considerable work has been carried out to advance nan-
otechnology and its applications. Nevertheless, our under-
standing of the general and occupational health and safety
aspects of NPs is still in its formative phase and greater effort
is needed to understand how NPs interact with the human
body [8, 9]. In this regard, nanotoxicology and nano-risk
have been attracting the increasing attention of toxicologists
and regulatory scientists [10] particularly in relation to the
unique properties of NPs that may render them potentially
more dangerous than their fine-sized counterpart and may
cause unexpected adverse health effects to exposed people
[6, 11].
Titanium dioxide (TiO2) is an example of a fine, white,
crystalline, odorless, low-solubility powder which was con-
sidered to exhibit relatively low toxicity [12–16]. It is a natu-
ral, thermally stable and nonflammable, nonsilicate min-
eral oxide found primarily in the form of the minerals
rutile, anatase, brookite, and as the iron-containing mineral
ilmenite [17–21]. It has excellent physicochemical properties,
such as good fatigue strength, resistance to corrosion,
machineability, biocompatibility, whitening and photocatal-
ysis, as well as excellent optical performance and electrical
properties [22, 23]. With regard to its potential adverse
health effects, several studies have defined TiO2, at least
under nonoverload conditions, as biologically inactive and
physiologically inert in both humans and animals and thus
as little risk to humans [24–27]. Pulmonary inflamma-
tion, fibrosis, epithelial hyperplasia, and tumorigenesis were
reported in animals under conditions of substantial TiO2
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particle lung burden due to sufficiently high dose and/or
duration of exposure [13, 15, 28, 29]. In 2006, the Interna-
tional Agency for Research on Cancer (IARC), classified and
in 2010 reassessed TiO2 as “possibly carcinogenic to humans”
on the basis of the sufficient evidence of carcinogenicity in
experimental animals and inadequate evidence in humans
(Group 2B) [28, 29].
TiO2 is a versatile compound that has broadly been used
in nanoparticulate form [21]. According to the National
Nanotechnology Initiative of America, nanosized TiO2 parti-
cles are among those most widely manufactured on a global
scale [30]. TiO2 NPs are widely used in paints, printing
ink, rubber, paper, cosmetics, sunscreens, car materials,
cleaning air products, industrial photocatalytic processes,
and decomposing organic matters in wastewater due to
their unique physical, chemical, and biological properties
(including the inherent advantages of physical stability,
anticorrosion and nanoscale-enhanced photocatalysis) [31].
However, the toxicological profile of TiO2 NPs is not
completely understood and several concerns have emerged
on the potential undesirable effects of the TiO2 NP prop-
erties, in regard to the harmful interactions with biological
systems and the environment [11]. The recently recognized
occupational carcinogenic potential of the inhaled TiO2 NPs
have ulteriourly enhanced these scientific concerns [15].
Therefore, an appropriate assessment of the risks for the
general and occupational exposed population requiring TiO2
NP hazard identification and dose-response data seems
necessary [32].
In this regard, our previous work [33] reviewed several
toxic effects of NPs assessed by in vitro experiments. These
studies represent a valid instrument to investigate TiO2 NP,
induced cellular changes at biochemical and molecular levels
and to determine their underlying mechanistic processes.
Moreover, providing interesting information about doses of
exposure and endpoint parameters to evaluate, this kind of
investigation constitutes a significant step in planning animal
research. Unfortunately, several limitations inherent to in
vitro assay/cell culture systems have appeared in simulating
the complex biological effects of particles administered to
experimental animals. These include, but are not limited to,
unrealistic particle dose, selection of cell types for simulating
the different system microenvironments (single-cell culture
systems or coculture systems), particle/cell exposure interac-
tions in culture versus biological fluids, time course of effects
represented by 1-, 4-, 24-, or 48-hour incubation in vitro
versus acute or chronic exposure in vivo, and appropriate
end points for hazard evaluation [34]. These biases do not
allow to obtain data that may be representative of human
exposure/effects and applicable for a correct population risk
assessment.
Therefore, in the present review, we will provide a com-
prehensive evaluation of the current knowledge regarding
the toxic effects induced by TiO2 NPs on organ systems
investigated in in vivo studies. This overview is intended
to be a useful tool to gain a thorough insight into the
toxicological profile of TiO2 NPs and to predict potential
human health effects. Moreover, it may reveal itself as a
valid instrument to extrapolate relevant data for human risk
evaluation and management and to identify those critical
aspects that deserve great attention in future population and
epidemiologic research.
2. In Vivo Studies
2.1. Respiratory System. Considering the relevance of the
respiratory system as a route for TiO2 NP exposure in
humans, the scientific community has focused on the
toxicological effects of these NPs on animal respiratory
models. Such experiments provide the basis to obtain more
detail data regarding the hazard of these NPs and to
extrapolate evaluations for a correct human risk assessment,
in particular, in relation to the characteristics of the particles.
Indeed, several animal pulmonary studies were carried out
to clarify the role played by TiO2 form, particle size, shape,
surface area, and chemistry in determining inflammatory
responses, particle lung distribution, and carcinogenic effects
(Table 1).
2.1.1. Inflammatory Responses
TiO2 Form. Regarding the TiO2 form, different studies have
demonstrated the pulmonary toxicity of acute exposure to
anatase in terms of increased bronchoalveolar lavage (BAL)
inflammatory parameters [35–38], lung tissue structural
damage, and inflammatory infiltration [22, 35, 36, 39, 40]
although it is modest in both acute and subacute exposure
[41]. However, as assessed by Liu et al. [36], only a slight
increase in toxicity from anatase exposure was evident
relative to rutile and P25 Degussa TiO2 NP treatments.
Only four studies have evaluated the ability of rutile TiO2
to induce toxic effects on lung tissues, reporting conflicting
results following acute [42–45] or subchronic exposure
[46]. While the first two studies demonstrated an increase
of inflammatory cells in BAL [43], alterations in gene
expression [42], and pathological changes in lung tissue
[42, 43], the latter two failed to reveal such changes [44–46].
When comparing the lung toxicity induced by rutile NPs
with that caused by P25 Degussa NPs, the former were not
able to induce alterations of the lung parameters examined
suggesting greater toxic effects of the mixture compared
to rutile alone [44, 45]. Regarding the toxic effects of P25
Degussa NPs on the lung, other studies have reported that
these particles are able to induce increased inflammatory
parameters in the BAL of acutely exposed animals [47,
48], though some interspecies differences in inflammatory
responses were evident in animals subchronically treated
[49]. The species differences detected between hamsters, rats,
and mice may reflect the capacity of some animals to rapidly
clear particles from the lung, as previously demonstrated
in the same species subchronically exposed to pigmentary
fine TiO2 particles [50, 51]. Interestingly, Gustafsson et al.
[48] demonstrated a dynamic inflammatory response to P25
Degussa NPs characterized by a transient innate immune
activation followed by a late-phase, long-lasting recruitment
of lymphocytes involved in adaptive immunity.
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Other mixtures of anatase and rutile particles were
also able to induce increases in BAL fluid inflammatory
parameters and lung histopathological alterations in rats
subacutely exposed by inhalation [66, 67], while mixtures
of anatase and brookite (3 : 1) failed to induce such effects
in mice after acute, subacute, or subchronic inhalations
[70, 76].
Other studies report similar changes after acute or suba-
cute exposure, such as increased levels of inflammatory
mediators in BAL [58, 59, 62, 73], enhanced reactive oxygen
species (ROS) production [59] and pathological alterations
at the histopathology examination of the lung [57, 73, 75]
but lack details regarding the TiO2 form. Interestingly, Baggs
et al. [57] demonstrated that chronic exposure to TiO2 NPs
induces lesions that are able to regress during a 1-year period
following cessation of exposure. Surprisingly, Cho et al. [32],
investigating the acute effects of intratracheal instillations of
TiO2 NPs, failed to demonstrate any alteration among BAL
inflammatory parameters and histological lung characteris-
tics. Finally, Liu et al. [74] demonstrated that intratracheal
instillation of not characterized TiO2 NPs damaged alveolar
macrophage (AM) phagocytic and chemotactic ability.
Size. Several studies described greater inflammatory effects
of NPs compared to their fine counterparts both after acute
[38, 53, 54, 62] and chronic exposure [53, 55].
In line with these results on NP size-related effects, a
more recent intratracheal instillation study [38] pointed out
that the smaller particles lead to greater inflammation in
short-term observations. In contrast, no clear relationship
was found between pulmonary inflammation and treatments
with different agglomeration states of the same primary TiO2
NPs.
Shape. The critical role of shape in TiO2 NP bioactivity
is supported by the increased markers of inflammation
detected in BAL of anatase nanobelt aspiration-treated mice
compared with those determined in animals treated with
TiO2 nanospheres [37].
Surface Area. High mass or volume dose of poorly soluble,
low-toxicity (PSLT) fine particles in the lungs has been
associated with overloading, while ultrafine particles impair
lung clearance at lower mass or volume doses [15]. The
increased lung retention and inflammatory response of
nanosized PSLT particles compared to fine PSLT particles
correlate better to the particle surface area dose [81, 82].
Indeed, the larger inflammatory response after TiO2 NP
treatment compared to larger particles may be ascribed to
an increase in NP surface area. This conclusion has been
questioned, and conflicting results are present in literature on
this topic. Some studies support the hypothesis that surface
area may be the more appropriate dose metric for TiO2
NP pulmonary toxicity studies [12, 60, 61]. When the same
mass doses were acutely introduced into rats and mice via
intratracheal instillation, TiO2 NPs induced a much greater
pulmonary-inflammatory response than fine TiO2 particles
[12, 60]. However, when the doses were normalized to the
particle-administered surface area, the response in the lung
for both nanosized and fine TiO2 particles showed the same
dose-response curve. Thus, in pulmonary toxicity studies,
surface area, for particles of different sizes but of the same
chemistry, proved to be a better dosemetric parameter than
particle mass or number.
However, other studies are in conflict with the notion
that the inflammatory response is expected to be more
severe with higher surface area NPs [39, 44, 45]. In fact,
similar BAL cell count alterations were reported in rats
after intratracheal administrations of the same dose of fine
rutile TiO2 particles, nanosized TiO2 anatase rods and dots,
although the latter had a >6-fold increase in surface area
compared with the nanorods [39]. In a subsequent study, the
same authors [44, 45] confirmed the previous evaluations
and concluded that having a larger surface area does not
necessarily indicate that NPs will produce greater pulmonary
inflammation and cytotoxicity compared to larger particles
of a similar composition. In line with the Warheit et al. [39,
44, 45] results, 2- to 5-nm anatase NPs (i.e., with the highest
surface area and smallest particle size) were not particularly
toxic in the Grassian et al. [41] subacute inhalation study.
Furthermore, in Li et al. [35], 3-nm anatase NPs did not
elicit more pulmonary toxicity compared to 20-nm NPs,
irrespective of their smaller size and greater surface area.
However, an aspect to take in consideration for a correct
interpretation of these data is the potential influence of “lung
overload” [13]. In the last decade, it has become clear that a
breakdown in normal AM-mediated clearance of particles is
seen in overload [83]. This is thought to be a consequence
of volumetric overload of the AM [84, 85] or a response
to the greater particle surface area per mass dose, as in the
case of NPs, which is associated with decreased AM clearance
and inflammation [13, 86]. In this regard, the importance
of the NP surface area overlaps with the role of the dose
administered to rats. Most of the studies herein described
showed greater TiO2 NP effects at higher exposure doses [35,
36, 39, 40, 43–45, 48, 49, 61, 62, 65, 67, 79]. Unfortunately,
the large dose range applied in these studies does not allow
one to establish a direct relationship between the different
treatments and pulmonary effects. Moreover, when a study
employes unrealistically high doses of NPs, such as in the
case of Chen et al. [22], its relevance is dubious at best. In
this light, when analyzing the NP dose role in lung damage,
caution should be applied in extrapolating data for human
evaluations.
Chemistry. Warheit et al. [44, 45] found that only non-
coated particles resulted in BAL alteration and lung histo-
pathological changes compared to their coated counterparts,
suggesting a possible influencing role of surface chemistry
in nano-TiO2-induced lung toxicity. In this regard, several
studies have investigated the influence of particle chemical
surface properties, surface coatings, and functionalization on
pulmonary responses showing conflicting results [61, 70, 77,
78].
Methylated-hydrophobic TiO2 NPs acutely decreased the
percentage of PMN and the protein concentration in BAL of
Journal of Nanomaterials 9
intratracheally administered rats [61], a result in line with
those of Oberdo¨rster [87], but in contrast with those of
Pott et al. [88] showing that hydrophobic, silanized TiO2
NPs induced acute mortality in intratracheally exposed rats.
Other studies reported significant inflammatory reactions
after acute [70, 79] and subacute [70, 77, 78] exposure to
coated NPs, particularly silica-coated rutile TiO2 NPs [70],
rutile TiO2 NPs surface modified with unspecified amount of
zirconium, silicon, aluminum, and coated with polyalcohols
[77, 78] and rutile Fe-doped TiO2 NPs [79]. However, at
present, it is unclear what changes lead to differences in the
toxicity induced by surface modified TiO2 NPs. In additional
experiments, P25 Degussa TiO2 NPs caused more persistent
pulmonary toxicity than carbon black NPs when compared
on an equivalent particle surface area basis [68].
On the other hand, several studies investigated the TiO2
NP role as an adjuvant in promoting allergic sensitization
or in influencing allergic lung inflammation. In this regard,
the results obtained by Larsen et al. [65] and Park et al.
[69] supported the adjuvant effect of not characterized and
P25 Degussa TiO2 NPs, respectively, through the promo-
tion of a T-helper (Th)-2 immune response assessed by
increased levels of interleukin (IL)-4, IL-5, and IL-10 in
BAL. These alterations could stimulate allergic reactions,
though the underlying mechanisms are not fully understood.
Interestingly, in two-day- and two-week-old rats, but not
in adult animals, subacute inhalation of P25 Degussa TiO2
NPs produced upregulation of lung neurotrophins which
was associated with a greater airway hyperresponsiveness
[72]. The age-dependent response to TiO2 NPs suggests
that the risk of developing asthma after NP exposure is
higher in the earlier stages of lung development. Hussain
et al. [80] demonstrated that intrapulmonary doses of TiO2
NPs can aggravate pulmonary inflammation and airway
hyperreactivity in a mouse model of diisocyanate-induced
asthma. Moreover, mixture of anatase and brookite TiO2
NPs caused airflow limitation in both acute and repeated 4-
week-inhalation exposures [76]. In contrasts to these results
[65, 69, 72, 76, 80], a recent study [71] demonstrated the
role of silica-coated rutile TiO2 NPs as inhibitors of most
soluble and cellular mediators of allergic asthma. In fact,
in ovalbumin-sensitized mice, the number of inflammatory
cells, and the airway hyperreactivity were dramatically
reduced after exposure to TiO2 NPs. The conflicting results
of the previous studies could be ascribed to the different
health status of the animals, the different type of particle
employed, or the different route of exposure. Rossi et al. [71]
hypothesized that anti-inflammatory Th-2 response caused
by allergen sensitizationmay be suppressed by the competing
proinflammatory response elicited by TiO2 exposure. How-
ever, future studies are needed to deeply clarify the TiO2
NP role in allergic reactions and the molecular mechanisms
involved.
2.1.2. Lung Distribution. Particle size was able to affect the
fate of NPs, particularly lung accumulation and distribution
in lung compartments, after pulmonary exposure. In fact,
several studies described greater NP lung amounts compared
to their fine counterparts [12, 52–55, 60]. Ferin et al. [53]
suggested that TiO2 particle passage in the interstitium
could be promoted by the smaller sizes of the particles
and the higher concentrations. Though data regarding the
accumulation of NPs in the interstitium are too limited
to allow a comprehensive evaluation of its consequences,
this aspect is of particular interest considering that particle
retention in the lung may give rise to potential enhancement
of local effects and the increased possibility of systemic
redistribution.
Translocation of NPs from pulmonary airways into other
pulmonary compartments, such as epithelium/endothelium,
connective tissue, the capillary lumen, or into systemic
circulation, is the subject of controversial discussion in the
literature. Two studies of the same group demonstrated
conflicting results in that regard [63, 64]. The first showed
that NP distribution was only related to the volume fractions
of the corresponding compartments [63], while the second
detected a correlation with the time points considered
[64]. In fact, it found that NPs were preferentially located
in the connective tissue and in the capillary lumen at 1
and 24 h after exposure, respectively. The epithelium and
the connective tissues were not deposition sites but only
passageways for NPs to reach the capillary circulation.
However, whether NPs can translocate from air-filled spaces
to the systemic circulation is still not fully understood, and
further investigation is needed.
2.1.3. Carcinogenic Effects. Animal and human epidemio-
logical data have led TiO2 to be designated as “possibly
carcinogenic” to humans [28, 29, 89]. Surprisingly, however,
few studies have investigated the carcinogenicity of TiO2
NPs, and only recently, NIOSH concluded that inhaled
ultrafine TiO2 is a potential occupational carcinogen [15].
The most relevant data for assessing the health risk for
workers are results from a chronic animal inhalation study
performed by Heinrich et al. [56], in which rats exposed by
inhalation to P25 Degussa TiO2 NPs showed increased rates
of adenocarcinomas compared to controls. Interestingly, in
this study, mice exposed to the same NPs, according to
the same methodology, did not show differences in tumor
rates compared to controls. Aside from demonstrating that
TiO2 NPs can induce lung cancer in exposed animals, an
interesting finding of this work is the difference in carcino-
genicity between rats and mice. The species difference
in response to insoluble and low toxicity dust, and the
controversial approach to classify such a dust as a potential
human carcinogen is subject to debate. Moreover, NIOSH
has concluded that TiO2 is not a direct-acting carcinogen,
but acts through a secondary genotoxicmechanism primarily
related to particle size and surface area [15], as supported
by the comprehensive analysis of the data reported by
Heinrich et al. [56] and those obtained by Lee et al. with
fine-sized TiO2 [90]. However, considering the pressing
concern regarding cancerogenic effects of TiO2 NP exposure
on general and occupational populations and the limited
number of in vivo studies on this topic, additional researches
seem highly necessary.
10 Journal of Nanomaterials
2.2. Nervous System. Regarding TiO2 NP neurotoxicity,
different studies have demonstrated the ability of these NPs
to translocate into the brain, irrespective of the route of
exposure [31, 73, 91–94], the form of the TiO2, and the
size of the NPs and to accumulate in this organ [31, 91–93]
inducing numerical and structural changes in the neuronal
architecture [31, 92, 93] (Table 2).
Several studies have unequivocally showed that rutile
TiO2 NPs, taken up by intranasal exposure, could be translo-
cated into the central nervous system (CNS) via the olfactory
pathway in mice and accumulate in the entire brain, mainly
in the hippocampus regions [31, 91, 92]. However, to verify
the generalization of this phenomenon, further studies are
needed in other animal species. Regardless, this neuronal
translocation pathway should be taken into account for
health risk assessments of TiO2 NPs. In particular, it could be
useful to avoid possible toxic effects to the general population
but principally to subjects that work with these NPs. Brain
accumulation was also demonstrated in mice intratracheally
instilled with no characterized TiO2 NPs able to penetrate
alveolar-capillary barrier, enter blood circulation, and fur-
ther penetrate blood-brain barrier inducing tissue damage
[73].
The deposition of TiO2 NPs in brain was reported to
induce changes in the release and metabolism of neuro-
transmitters, although with the same conflicting results,
maybe due to the different route of exposure [31, 91, 93,
94]. Particularly, the levels of norepinephrine (NE) and 5-
hydroxytryptamine (5-HT) increased after intranasal expo-
sure [91] while decreased in response to intragastric admin-
istrations of anatase TiO2 NPs [93]. Dopamine (DA), 3,4-
dihydroxyphenylacetic acid (DOPAC), homovanillic (HVA),
and 5-hydroxyindole acetic acid (5-HIAA) contents were
reduced by both types of treatment [91, 94]. Moreover,
intranasal instillation of rutile [31] and intragastric admin-
istrations of anatase TiO2 NPs [94] increased catalase
and acetylcholinesterase (AchE) activity, soluble protein
carbonyl, acetylcholine (Ach), glutamic acid (Glu), and
NO content. Intraperitoneally injected anatase TiO2 NPs
increased NO, while decreased Glu content and AchE activity
[92]. Interestingly, the study performed by Hu et al. [94]
demonstrated also that the contents of Ca, Mg, Na, K,
Fe, and Zn in brain were significantly altered after TiO2
NP exposure. The disturbed homeostasis of trace elements,
neurotransmitters, and enzymes in brain may be responsible
of the spatial recognition memory impairments reported
in treated mice [94]. However, as assessed by a proteomic
analysis, proteins of the mouse brain resulted differentially
expressed in response to TiO2 NP treatment even if NPs were
not detected in the tissue [95].
As observed in vitro [96–98], oxidative stress-related
damage with a consequent alteration in the balance between
oxidative and antioxidative activities was also reported
in in vivo studies [31, 73, 92, 93, 95]. Malondiadehyde
(MDA) levels increased after intranasal instillations [31, 92],
intraabdominal injections [93], and intratracheal instillation
in mice [73]. Similarly, Li et al. [73], and Ma et al. [93]
demonstrated that the level of superoxide anion (O2
−), per-
oxide (H2O2) [73, 93] and hydroxyl radicals [73] increased
in treated animals. TiO2 NPs are able also to induce an
inflammatory effect in brain of treated mice, as detected
by the increased cytokine release [92, 99]. In the latter
study, rutile and P25 Degussa TiO2 NPs intraperitoneally
injected in mice after lipopolysaccharide (LPS) increased the
mRNA levels of IL-1β and tumor necrosis factor (TNF)-α
and also those of IL-1β protein. Interestingly, LPS induction
was necessary to cause this phenomenon, suggesting the
importance of a trigger element or of a possible synergistic
effect in tissue responses to TiO2 NPs.
Finally, several studies demonstrated the embryotoxic
role of maternal intravenous injection of no characterized
TiO2 NPs [100], or subcutaneous injections of anatase TiO2
NPs [101–103]. Following this latter treatment, TiO2 accu-
mulation was detected in the offspring cerebral cortex and
olfactory bulb and numerous olfactory bulb cells resulted
positive to markers of apoptosis [101]. Moreover, the same
prenatal exposure induced an altered expression of genes
involved in brain development, cell death, and the response
to oxidative stress in the newborn pups [102]. Finally, the
influence of prenatal TiO2 NP exposure on the dopaminergic
system was demonstrated by the increased DA, DOPAC,
HVA and 3-methoxytyramina hydrochloride levels in the
prefrontal cortex and in the neostriatum of exposed mice
[103].
These data confirm that TiO2 NPs can be transferred
from mothers to the fetal brain, inducing toxic effects on
fetal brain development carrying a series of nervous system
disorders. In this context, a deep knowledge regarding the
influence of TiO2 NPs on neuronal cells is becoming urgent.
Though additional studies are necessary to support these
findings, they should be taken in consideration for the
correct risk assessment of TiO2 NP exposure, particularly
during a complex biological status like pregnancy and the
early stage of life.
2.3. Dermal and Mucosal System. Studies regarding the
effects of TiO2 NPs on the dermal system (in particular, the
percutaneous absorption of NPs) show more homogeneous
findings, demonstrating a clear absence of penetration
through the intact epidermal barrier when TiO2 NP formula-
tions are applied on different animal [104, 105] and human
[106–110] skins (Table 3). Considering the widespread use
of TiO2 NPs in cosmetic sunscreens (due to their broad-
spectrum UV absorption and high esthetical acceptance)
[107], this is an important finding.
Sadrieh et al. [104] analyzed the correlation between
different forms of TiO2 and percutaneous absorption in
micropig skin, demonstrating that irrespective of the form,
after a subchronic exposure, NPs were found in the stratum
corneum but not in the deeper epidermal strata. Anatase
TiO2 NPs subacutely exposed to hairless rat skin were only
detected in the horny layer of the interfollicular epidermis,
without penetration into viable cell layers or induction of any
cellular changes [111].
Neither the shape [104, 105, 107, 108] nor the surface
chemistry [107–109] seems to influence NP penetration after
acute and subacute exposure.





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Journal of Nanomaterials 15
Pflu¨cker et al. [107] demonstrated that all TiO2 NP types
applied on skin areas of human forearm were only detected
on the outermost layer of the stratum corneum, irrespective
of their surface chemistry, NP size, and shape. The same
results were confirmed by Schulz et al. [108]. Similarly, after
application of lanceolate TiO2 NPs on the backs of pigs, high
concentrations of Ti were found in the stratum corneum and
granulosum, but not into the stratum spinosum [105].
Mavon et al. [109] demonstrated that 93% of the TiO2
T805 NPs hydrophobically coated with trimethyloctylsilane
applied on human upper arms were found in the stratum
corneum, decreasing continuously with depth. No TiO2
penetration into viable skin layers was assessed confirming
the in vitro findings of the study.
The studies investigating the Ti penetration and distri-
bution in biopsies obtained from human skin grafts trans-
planted into severe combined immune deficiency (SCID)
mice could only detect Ti in the outermost layers of
the stratum corneum of the skin biopsies, irrespective of
the various NP formulation applied and the time points
considered (1–48 h) [106, 110].
As also confirmed byMenzel et al. [105], Lademann et al.
[113] failed to demonstrate a role for hair follicles as a
percutaneous absorption pathway. In fact, Ti was detected in
the stratum corneum and in the follicle channels but not in
the interfollicular space under the stratum corneum or into
the viable layers of the forearm skin of human volunteers.
Only a few reports detail Ti penetration into human
dermis [112, 115]. For instance, in a pilot study conducted
in 1996, Tan et al. [112] demonstrated percutaneous pen-
etration of Ti in patients subchronically applied sunscreen
containing microfine TiO2. Although Ti levels in the dermis
of exposed subjects were higher than controls, these results
were not statistically significant and were not confirmed by
subsequent studies. Moreover, Wu et al. [115] reported the
ability of TiO2 NPs in different form, anatase, rutile, P25
Degussa, and different sizes to penetrate through the skin,
reaching different tissues (e.g., liver, spleen, and heart) where
pathological lesions were induced after subchronic dermal
exposure of hairless mice. Moreover, increased MDA levels
were determined in the skin, which also showed excessive
keratinization, thinner dermis and wrinkled epidermidis.
These data could not be confirmed when reared pigs were
treated with two types of the previously employed NPs for
shorter periods of time.
The same interesting points of discussion emerged from
this latter study. It seems that the penetrative ability of similar
TiO2 NPs into the cutaneous layers depends on the animal
species studied and on the period of exposure. Furthermore,
pathological skin lesions due to NP application are likely
ascribed to oxidative stress, which was also detected on
human and murine dermal fibroblasts in vitro [118–120].
Intradermal injection of TiO2 NPs aggravated atopic
dermatitis (AD) symptoms related to mite allergen in mice
assumed to show skin barrier dysfunction/defect through
Th-2 immune inflammatory responses and histamine release
[114]. These data support the importance of an intact dermal
defense system to prevent uptake of TiO2 NPs, which can
lead to skin damage, activation of the immune system, and
eventually a decrease in the allergy threshold [105].
Ultimately, the importance of the human studies on per-
cutaneous TiO2 absorption is underlined by the fact that
these experiments alone are able to provide a relevant ap-
proach to direct human risk assessment and are the first step
in the complex process of generalizing implications regarding
environmental or occupational health.
Regarding skin carcinogenicity, conflicting results were
reported [116, 117]. Tumor growth was increased when mice
were intraperitoneally injected with TiO2 NPs prior to the
subcutaneous implantation of B16F10 melanoma cells [116].
The authors suggest that TiO2 NPs might have the potential
to enhance tumor growth in situ through immunomod-
ulation of B- and T-lymphocytes, macrophages, and NK
cells as supported also by results obtained in the spleen
tissue. In contrast to these findings, Furukawa et al. [117]
investigated the safety of coated and uncoated TiO2 NPs in
a mouse medium-term skin carcinogenesis bioassay. Both
TiO2 NPs applied to mouse skin in the postinhitiation
phase did not increase the development of skin nodules
histopathologically diagnosed as squamous cell hyperplasia,
sebaceous gland hyperplasia, squamous cell papilloma, and
keratoacanthoma. According to these data, TiO2 NPs do not
possess postinhitiation potential and there is no carcinogenic
risk relevant to percutaneous application of TiO2 NP prepa-
rations.
2.4. Cardiovascular System. Due to the complexity of the car-
diovascular system, studies regarding the potential effects of
TiO2 NPs on this system have focused on different functional
aspects, such as cardiotoxicity [121, 122], cardiovascular pa-
rameters, such as systolic blood pressure (SBP) and heart rate
(HR) variability [79], induction of thrombosis [22, 123], and
the alteration of vasomotor responses [124–128] (Table 4).
TiO2 NPs are able to induce high LDH, creatine kinase
(CK), alpha-hydroxybutyrate dehydrogenase (HBDH), and
aspartate aminotransferase (AST) activities used as markers
of myocardial lesions, irrespective of the form of TiO2,
anatase [122] or a mixture of anatase and rutile [129], or the
route of exposure, intraperitoneal injections in mice [122],
or oral gavage in rats [129]. Moreover, acute cardiotoxicity,
in terms of higher serum LDH and alpha-HBDH enzymes,
was demonstrated after a single oral gavage of TiO2 NPs
administered to mice [121]. Unfortunately, the lack of data
regarding the LDH isoform prevents a clear correlation
between these increases and cardiac insults. Moreover, the
study performed by Wang et al. [121] did not provide
information on TiO2 form, and consequently, it does not
allow comparisons with the two previous described works
[122, 129].
When intratracheally instilled in rats, rutile Fe-doped
TiO2 nanorods significantly increased SBP and HR in treated
animals, which could be the consequence of the systemic
inflammation induced by the same particles [79].
Regarding the TiO2 NP prothrombotic effect, the cur-
rently available data are conflicting. For instance, Chen et al.
[22] observed thrombosis in the pulmonary vascular system




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Journal of Nanomaterials 17
of mice treated via intraperitoneal injection with anatase
TiO2 NPs. On the contrary, Bihari et al. [123] failed to
confirm thrombosis induction in both the mesenteric and
cremasteric circulation of mice given parentally rutile TiO2
NPs. The higher exposure dose used by Chen et al. [22]
compared to that of Bihari et al. [123], up to 2592mg/kg
versus 1mg/kg, respectively, may be responsible for the
induction of thrombosis ascribed to the blockage of blood
vessels by TiO2 particles. Moreover, the difference in the
form of TiO2 used by these two studies may explain some
differences in the results. However, the very limited number
of in vivo and in vitro studies on this regard does not
support such conclusions. Thus, further studies are necessary
to confirm these results and to investigate the mechanism(s)
leading to thrombus formation.
The vasomotor response of the spinotrapezious muscle
arterioles is impaired by P25 Degussa TiO2 NP inhala-
tion [124, 125]. This vascular impairment was due to a
dose-dependent reduction in NO endothelium production
induced by microvascular oxidative and nitrosative stress
[125]. Local ROS production may consume endothelium-
derived NO or compromise NO endogenous production
leading to vascular dysfunction as confirmed by a partially
restored NO production by radical scavenging.
The loss of microvascular vasodilator capacity can sig-
nificantly influence the normal homeostasis in any organ,
causing impairment of tissue perfusion and compromising
organ function. In this context, a further study by the same
group demonstrated that after TiO2 NP exposure, coronary
arteriole response to vasodilators was impaired though
with conserved responsiveness to NO [126]. As previously
detailed, the role motive of the increased microvascular ROS
production was confirmed by the restored impairment after
incubation with ROS scavengers [127].
Finally, vasomotor responses of intralobar pulmonary
arteries removed from rats intratracheally exposed to
Degussa TiO2 NPs were not altered in a study carried out
by Courtois et al. [128]. The ex vivo contractile response to
prostaglandin F2α and KCl and the relaxant response to Ach
were not altered by TiO2 NP treatment [128, 130].
However, without appropriate particle characterization,
it is difficult to compare findings between toxicological
studies. Future studies are necessary to provide deeper
knowledge regarding the toxic effects of TiO2 NPs on the
cardiovascular system.
2.5. Liver. The toxic effects of TiO2 NPs on liver function
were demonstrated in several studies through the detection
of increases of AST, alanine aminotransferase (ALT) [21,
22, 79, 121, 122, 129, 131–133], ALP, pseudocholinesterase
(PChE), leucine acid peptide (LAP), TP, ALB [21, 40, 122,
132, 133], and globulin (GLB) levels. Decreased ALB/GLB
ratios [21, 132] and increased ALT/AST ratios, a more
sensitive indicator of hepatic injury [121, 131, 134], have also
been detected (Table 5).
These results were obtained irrespective of the form
of TiO2, particularly anatase [22, 40, 115, 122, 132–135],
rutile [79, 115] and P25 Degussa TiO2 NPs [115]; the NP
different size [115, 121] and shape [79]; the modified surface
chemistry of the particles [79].
Other studies demonstrated TiO2 NP hepatotoxicity
effects, in terms of increased ALT levels and ALT/AST ratio
both after a single oral administration [121] or repeated
intraperitoneal treatments in mice [122], unfortunately,
without reporting details regarding the form of TiO2 used.
Moreover, the route of exposure, such as the intragastric
[21, 121, 129, 133, 136], intraperitoneal [22, 122, 131, 132],
intratracheal [40, 75]; dermal [115], or intraarticular [134],
does not seem to determine different toxic effects on liver
function, both in terms of type and entity of manifestation.
The intraarticular administration was used by Wang et al.
[134] to simulate the release of NPs into joint cavities
from the nanocoated surface of prostheses considering the
good prospects for application of nanomaterials in prosthetic
implants.
Interestingly, anatase, rutile, and P25 Degussa TiO2 NPs
were able to penetrate the dorsal skin of hairless mice and
to accumulate in the liver inducing oxidative stress, and
focal necrosis in the parenchyma [115]. The potential role
of an oxidative attack in causing liver damage was recently
demonstrated in mice intragastrically [136] and intraperi-
toneally [135] exposed to nanoparticulate anatase TiO2. ROS
accumulation, lipid peroxidation, and altered expression of
genes involved in antioxidative or detoxification processes
were triggered by NP treatment [136].
Interesting results were obtained by Li et al. [137]
analysing the interactions between anatase TiO2 NPs and the
DNA extracted by the liver of mice intraperitoneally exposed.
They reported that nanoanatase TiO2 could be inserted into
DNA base pairs, bind to DNA nucleotide, and alter the
secondary structure of DNA.Moreover, NPs could cause liver
DNA cleavage and hepatocyte apoptosis [137].
Several studies also detected signs of hepatic dam-
age in terms of histopathological changes and hepatocyte
ultrastructural alterations that could lead to impaired liver
function [21, 22, 115, 121, 132, 134], while only few did
not confirm these results [30, 129]. Particularly, hepatic
fibrosis hydropic [22, 121] and fatty [133, 134] degeneration
of hepatocytes, prominent vasodilatation [21, 132], and
focal ischemia were induced by TiO2 NP treatment [132].
Necrotic [22, 121, 133] and apoptotic cells [132, 133, 136]
were detected, and infiltration of inflammatory cells was
also found [22, 79, 132–134]. The inflammatory reaction
in response to NP insult was also confirmed by significant
increase of both mRNA and protein expression levels of
several inflammatory cytokines and mediators in liver of
treated mice [132, 133].
Regarding the metabolic homeostasis of mice treated
with TiO2 NPs, several studies demonstrated increased
contents of triglycerides (TG), total cholesterol (TCHO)
[21, 122, 132], high-density lipoprotein cholesterol (HDL-
C) [122, 132], and glucose [122] compared to controls, while
low-density lipoprotein cholesterol (LDL-C) resulted lower
[132].
Moreover, recent metabonomic studies, demonstrated
the ability of TiO2 NPs to cause a series of changes in
endogenous metabolite levels in the 1H nuclear magnetic


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Journal of Nanomaterials 21
Resonance (NMR) spectra of urine and serum [40, 75, 129],
both after repeated intragastric doses of a mixture of rutile
and anatase TiO2 NPs [129] and after acute intratracheal
instillation of no characterised TiO2 NPs [75]. These findings
support the role of TiO2 NPs in leading disturbances in the
energy and amino acids metabolism through hepatotoxic
effects and confirm the changes in liver function previously
described.
Regarding the intravenous exposure, Yamashita et al.
[100] detected TiO2 NPs in fetal liver after NP injections into
pregnant mice, Fabian et al. [138] failed to show any hepatic
toxicity in rats treated with injection of a mixture of anatase
and rutile TiO2 NPs.
Negative results in terms of alteration in liver parameters
were reported also in rats treated with a single intratracheal
instillation of TiO2 NPs [30]. Interestingly, in this study,
even if functional and histological liver lesions could not be
demonstrated, hepatic superoxide dismutase (SOD) activity
was reduced, and MDA levels were increased suggesting
a possible role of oxidative stress and lipid peroxidation
generated by NP exposure, perhaps as an early sign of
damage, previous to clear functional parameter alterations.
These findings are in line with the in vivo results previously
detailed [115, 135, 136] and those obtained in vitro by Shi
et al. [139] showing increased ROS and MDA in TiO2 NP-
exposed hepatocytes.
In conclusion, though all of the studies reviewed in this
section concentrate on hepatotoxic effects of TiO2 NPs, the
current knowledge in this field is not yet exhaustive, and
further investigation is necessary to fully elucidate the patho-
genesis of the liver damage and the potential relationship
between liver toxicity and the different characteristics of NPs.
Interestingly, the interactions between TiO2 NPs and DNA,
both direct or indirect, such as those mediated by oxidative
stress, deserve greater attention in order to the understand
their potential role in the mechanisms underlining genotoxic
and carcinogenic effects. Moreover, no data are present in
literature on the in vivo effects of NPs on the gastric and
intestinal systems, and only limited studies on cells of the
latter system have been performed in vitro. In our opinion,
this aspect should be deeply investigated in future research
due to its great importance, particularly considering the
possibility of NPs penetrating into organisms through the
intestines.
2.6. Hematopoietic and Immunological Systems. Only few
studies have investigated the influence of TiO2 NP exposure
on hematological parameters reporting conflicting results
(Table 6). Evidence for NP-related upregulation of systemic
inflammation, assessed by increased white cell count, was
provided by several studies [43, 79, 129], whereas Duan et al.
[21] failed to confirm these findings. Particularly, they
demonstrated that the reduced levels of CD3, CD4, CD8-
competent T lymphocytes, B, and natural killer (NK) cells
and the reduced ratio of CD4 to CD8 detected were a clear
sign of a disturbance of the cellular immune function and of
the inhibition of the immune response of mice. Differences
in the TiO2 form used, rutile [43, 79] versus anatase [21]
versus a mixture of the two [129], the shape of the particles,
nanorods [43, 79] versus NPs [21, 129], administration
route, intratracheal [43, 79] versus intragastric [21, 129],
and the length of exposure, acute [43, 79] versus subchronic
[21, 129] may account for the discrepancies between the
previous reviewed studies.
Moreover, Nemmar et al. [43] detected a reduced
number of platelets in vivo due to a possible aggregation
confirming the results obtained by the same authors in vitro.
Unfortunately, these results were not confirmed when rats
were intratracheally exposed to Fe-doped TiO2 nanorods,
suggesting a potential role of the particle surface chemistry
in influencing hematological effects in vivo [79].
However, all of these data should be interpreted as
preliminary results and must be confirmed by future studies.
Other recent works have also investigated the effects of
anatase TiO2 NPs on a key organ of the immunological
system, the spleen, following both intraperitoneal injections
[22, 116, 122, 140] or intragastric administrations [141]
(Table 6). These studies revealed that TiO2 NPs are able
to accumulate in the spleen in a dose-dependent manner
[22, 122, 140] inducing histopathological damage. Apoptotic
morphological changes [140], accumulation of neutrophils
[22], congestion of the splenic tissue, and lymph node
proliferation [140, 141] were detected. Moreover, reduction
in total splenocyte, CD4 and CD8 T-lymphocyte number,
retardation in B-lymphocyte development, and reduction in
LPS stimulated NK cells were reported after exposure to TiO2
NPs [116].
A recent study [71], demonstrated that, in ovalbumin-
sensitized mice, silica, coated rutile TiO2 NP inhalation
decreased TNF-α and IL-13 expression in spleen cells.
On the other hand, Wang et al. [121] failed to reveal
abnormal pathological changes in mouse spleen after a single
intragastric administration. Unfortunately, this study lacks
details regarding the form of the TiO2 employed.
TiO2 NPs induced increased ROS and MDA in the spleen
[140, 141] and decreased levels of SOD antioxidant activity in
plasma after intratracheal instillation in rats [30]. Oxidative
stress was thought to play an important role in triggering the
mitochondrial-mediated apoptotic pathway demonstrated in
the spleen tissue [140].
However, the limited number of studies investigating the
hematological and immunological effects of TiO2 NPs do not
allow comparison and extrapolation of certain conclusions.
Further research is necessary to confirm these results and to
shed light on the roles of NP characteristics in inducing the
alterations described above.
2.7. Renal System. Several studies report alterations, al-
though opposite in some cases, of renal functional param-
eters, such as increased [40, 75, 121, 131] and reduced
[122, 134, 142] blood urea nitrogen (BUN), increased [75,
121, 142] and decreased [134] creatinine (Cr), and reduced
uric acid (UA) levels [122, 142] (Table 7). The impact
of TiO2 NP treatment on the renal function was ulte-
riourly confirmed by the altered levels of metabolic products
in the urine and serum of intratracheally exposed rats




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































26 Journal of Nanomaterials
investigated by 1H NMR analysis [40, 75]. However, the clear
interpretation of these data and the causative mechanisms
are not fully understood. Unfortunately, of these studies, only
few characterize the TiO2 form used as anatase [40, 122,
134, 142], while the others lack TiO2 particle characterization
[75, 121, 131]. Moreover, the different routes of exposure
employed to investigate nephrotoxicity, such as intraperi-
toneal [122, 131, 142], intra-articular [134], intragastric
[121], and intratracheal [75] administrations, do not allow
a clear comparison of the results obtained.
On the other hand, different studies did not report TiO2
NP-induced nephrotoxicity neither following intravenous
exposure to a mixture of anatase and rutile [138] nor
after anatase intraperitoneal injections [22], nor following
intratracheal instillation with no characterized TiO2 NP
suspension [30]. In this latter study, pathological changes
were not observed in kidney tissues. In contrast, renal
glomerulus swelling [22] and deposition of proteinic liquid
in renal proximal tubules were described [22, 121, 134], also
without functional damage [22].
The role of oxidative stress as a possible triggering mech-
anism for TiO2 NP inducing kidney damage was demon-
strated by increased ROS generation [142], enhanced lipid
peroxidation [30], as well as decreased SOD, catalase, ascor-
bate peroxidase, and glutathione peroxidase (GSH-Px) anti-
oxidant activities [30, 142]. Surprisingly, these changes were
detected also in a study where functional alterations were
not present, suggesting their role as an early sign of damage,
previous to clear functional parameter alterations [30].
These fragmented data require confirmation and further
investigation, which should focus on the role played by
the different characteristics of TiO2 NPs in inducing such
alterations.
2.8. Musculoskeletal System. Two studies investigated the
biological tolerance of TiO2 NPs when implanted in rat living
tissues [143, 144] (Table 8). Interest in this type of research
emerges from the promising utilization of NPs in numerous
fields of medicine and the not fully understood potential
reactions at the tissue-material interface. Inflammation and
granulomas were detected in the vicinity of intramuscularly
implanted TiO2 NPs as a normal reaction to a “foreign body,”
but no signs of intolerance were observed in both studies at
6 or 12 months postimplantation.
Moreover, an inflammatory reaction, characterized by
hypertrophy of the sinovial membrane, infiltration of lym-
phocytes and plasma cells, and proliferation of fibroblasts,
was observed in rat knee joints when TiO2 NP suspensions
were intraarticularly injected [134]. NPs were also able to
stimulate oxidative stress as demonstrated by increases of
antioxidants, such as GSH-Px and SOD activities, which were
elevated to overcome an increase in ROS production.
TiO2 NPs were able to convert benign nonmetastatic
tumor cells into malignant metastatic ones in a manner
dependent on the NP surface chemistry and the ability to
produce ROS in the target cells [145]. In particular, poorly
tumorigenic and nonmetastatic QR-32 fibrosarcoma cells
became tumorigenic only after injection into subcutaneous
sites previously implanted with hydrophilic ZrO2Al(OH)3-
treated TiO2 NPs. Moreover, tumor cell lines derived from
the QR-32 cells of both TiO2 NP preimplanted sites acquired
a pulmonary and extrapulmonary metastatic phenotype
when intravenously injected in mice. Both the 8-hydroxy-
2′-deoxyguanosine (8-OHdG) adduct and 4-hydroxy-2-
nonenal-positive cells, induced by oxidative stress action,
were increased in the hydrophobic ZrO2Al(OH)3 plus steric
acid-treated TiO2 NP implantation sites compared to the
hydrophilic one.
In conclusion, future research should investigate muscu-
loskeletal tissue-TiO2 NP interactions, especially considering
the potential widespread utilization of TiO2 NPs in biomed-
ical products.
2.9. Reproductive System. Only few studies investigated the
effects of TiO2 NPs on the male reproductive system [101,
131] (Table 8). Guo et al. [131] demonstrated reductions
in sperm density and motility and an increase in sperm
abnormality and germ cell apoptosis in mice treated with
intraperitoneal injections of TiO2 NPs. Testes and epididymis
did not show pathological changes.
When mice were prenatally exposed to anatase TiO2 NPs
via subcutaneous injections of dams they showed aggregates
of NPs in Leydig cells, Sertoli cells, and spermatids in
the testes [101]. Disorganized and disrupted seminiferous
tubules, tubule lumens with few mature sperm, as well
as decreases in daily sperm production, epididymal sperm
motility, and numbers of Sertoli cells were also observed
[101, 146].
Such limited knowledge regarding the reproductive tox-
icological effects of TiO2 NPs and the relevance of this topic
makes future investigations a matter of urgency.
2.10. Genotoxicity. TiO2 NP genotoxicity is poorly studied
in vivo, and the mechanisms involved have not been
clearly defined. To our knowledge, only two studies have
investigated in vivo genotoxic effects and report contrasting
results (Table 9). One study [147] demonstrated that TiO2
NPs are inert to lung cells, while the other [148] found that
NPs induce genotoxicity in organs such as the blood, bone
marrow, and embryos.
Specifically, Rehn et al. [147] showed that both hydro-
philic P25 Degussa TiO2 NPs and hydrophobic trimethoxy-
octylsilane-treated T805 TiO2 NPs intratracheally instilled
in rats failed to induce persistent inflammation in BAL.
The single lung cell immunohistochemical detection of 8-
oxoguanine revealed no differences between both NP-treated
groups and controls.
Trouiller et al. [148] exposed adult and pregnant dam
mice to water supplemented with solutions containing P25
Degussa TiO2 NPs. Eyespots, a measure of DNA deletion,
increased in in utero TiO2 NP-treated mice compared to
controls. A dose-dependent increase in DNA double-strand
breaks was also detected in bone marrow cells and an
increased tail moment was evident in peripheral white blood
cells of treated mice. MN frequency and the level of 8-
OHdG were higher in peripheral blood erythrocytes and in


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Journal of Nanomaterials 29
the livers of TiO2 NP-exposed mice, respectively. Moreover,
TNF-α, interferon (INF)-γ and the mouse orthologue of
IL-8 were increased after exposure. These studies evalu-
ated both genotoxic effects and inflammatory parameters,
because most in vitro TiO2 NP genotoxicity studies have
suggested that NPs could damage DNA directly or indirectly
via oxidative stress and/or inflammatory responses [148].
The discrepancies between in vivo results reproduce the
conflicting in vitro findings [33]. However, though the
limited number of in vivo studies does not allow one to
extrapolate conclusions, we hypothesize that different TiO2
forms, particle sizes, degrees of aggregation, preparation
methods, incubation conditions, doses, and susceptibility
between cell types influence responses to TiO2 NPs.
Interestingly, the study carried out by Trouiller et al.
[148] is the first showing that DNA deletions in offspring
are increased by in utero exposure to TiO2 NPs. This finding
is of great importance considering the high susceptibility of
embryonic cells to DNA damage and widespread environ-
mental and occupational TiO2 NP exposure.
In conclusion, there are concerns regarding the potential
risk of genetic disorders, particularly for people occupa-
tionally exposed to high doses of TiO2 NPs. Thus, further
research is necessary to fully understand genotoxic TiO2 NP
effects and to determine the conditions in which they occur
to fully evaluate NP exposure risks.
3. Discussion
Our analysis pointed out interesting and critical aspects, par-
ticularly in relation to the interaction between NP-induced
effects and remarkable treatment parameters, such as routes
of exposure, TiO2 form, NP size, and surface reactivity, that
we argue will be the focus of future research. In all the studies
reviewed, the commonly proposed pathogenic mechanisms
initiated by TiO2 NPs are dominated by inflammation-driven
effects, including fibrosis, oxidative stress, and DNA damage,
making inflammation a target for toxicological testing [7,
11, 149, 150]. Regarding the respiratory tract, which is
considered the most affected organ, lung overload is thought
to be responsible for the induction of inflammation, ROS
production, and ultimately lung damage. Indeed, it should be
carefully evaluated in future studies for both its “volumetric,”
“mass,” and “surface area” determinants. Future research will
be also necessary to clarify which NP characteristic could
play a triggering role in the cascade of events responsible
for lung injury. Moreover, a correct evaluation of the risk
derived from TiO2 NP respiratory exposure should be
performed in consideration of the significant role of this
route of exposure for both the general and occupational
populations. Particularly, in the latter setting, an appropriate
risk assessment focused on the pattern of absorption, the role
of the total inhaled amount, direct lung alteration, and/or
damages in other distant organs, could greatly influence both
the risk communication and the risk management phases,
the adoption of valuable methods of environmental and
biological monitoring, and the measures of collective and
individual protection.
Interestingly, inhaled TiO2 NPs resulted able to be trans-
locate to the CNS via the axons of sensory neurons in the
upper respiratory tract [31, 91, 92]. This is an intriguing
aspect because it introduces a route for TiO2 NP exposure
directly linked to the CNS, in which NPs could elicit their
toxic effects. These findings underscore the need for addi-
tional studies to further elucidate underlying mechanisms
and to characterize the physiological impact, particularly
in relation to which NP characteristics could influence
this passage. The confirmation of this potential route of
exposure may be extremely important for the general and
occupational population, because the direct translocation of
NPs to the CNS through the olfactory bulb could requires
greater attention in public and workplace settings, as well as
the urgent adoption of adequate protective measures.
Dermal studies have shown that there is currently little
evidence for skin penetration and systemic exposure after
dermal applications of TiO2 NPs used in sunscreens [107,
109, 112, 113]. However, the open question has been raised
as to whether the usual testing with healthy, intact skin is
sufficient [151, 152].
Regarding other organs, the data are too limited to
extrapolate general concepts, and additional studies are
required, which may offer new details regarding TiO2 NP
absorption, systemic uptake, and kinetics, providing a deeper
knowledge of the TiO2 NP toxicological profile. In this
context, it could be helpful to investigate new, noninvasive,
powerful techniques aimed to identify early pathological
metabolic and toxicological processes induced by NPs [40,
153–155]. Among these methods, metabonomics provide a
relatively complete biological summary of the whole body
response to NPs, and an appropriate identification of tissue
damage biomarkers [40].
Moreover, while TiO2 has been classified as possibly
carcinogenic to humans (Group 2B) [28, 29], no definite
conclusion is present for TiO2 NPs. The NIOSH recently
determined that inhaled ultrafine TiO2 is a potential occu-
pational carcinogen and recommended an exposure limit
of 0.3mg/m3 for ultrafine (including engineered nanoscale)
TiO2 as a TWA concentration for up to 10 hr/day during a
40-hour work week [15]. This conclusion was due to weight
of scientific data demonstrating TiO2 NP carcinogenic effect
on rat lungs [56]. Interestingly, NIOSH has reviewed that
the tumor response observed in rats exposed to TiO2 NPs
resulted from a secondary genotoxic mechanism involving
chronic inflammation and cell proliferation [15]. The central
hypothesis is that inflammation leads genotoxic events as
well as cell proliferation and tissue remodeling, which are
processes that are all required for mutations and progression
towards neoplastic lesions [156]. However, the mutagenic or
epigenetic mechanisms underlying the TiO2 NP carcinogenic
action need ulterior confirms and their role in the multistep
process of carcinogenesis, likely as trigger of the initiation,
promotion or progression phases of tumor manifestation,
should be deeply elucidated [33]. This argument merits
much attention in future studies with a particular focus
on the conditions in which TiO2 NP genotoxicity and
carcinogenicity occur particularly in relation to the potential
influence played by different particle production, size, degree
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of aggregation, preparation method, exposure conditions,
dose, and susceptibility of animal species [33, 148, 157, 158].
These results will be of great importance in order to deeply
characterize the risk of TiO2 NP exposure and to define
suitable exposure limits.
The relevance of the toxicological research in animals
lies on the possibility to evaluate the type and entity of
the adverse response induced by different doses of TiO2
NPs and to extrapolate threshold levels aimed to protect
exposed human populations. The general dose-response
model indicates that the higher the concentration of a
chemical substance, the greater is the influence on the
organism [5]. However, in nanotoxicological research, the
dose-response relationship requires special attention consid-
ering that the traditional mass dose does not well reflect
the biologically effective dose for NPs. Other dose metrics,
such as surface area combined with surface reactivity or
the particle number, should be evaluated as ulterior, maybe
better, descriptors of the potential to cause damage at the
site of particle deposition or far from this [32, 82, 159, 160].
In this context, a TiO2 NP standardized characterization
including parameters like TiO2 form, NP number, and mass
concentration, size, shape, state of agglomeration, charge,
crystallinity, solubility, oxidant generation capacity, added
functional groups, or impurities and rate of dissolution is
the first step to a comprehensive identification of the TiO2
NP hazard [2, 7]. It seems necessary to focus future research
on establishing a matrix of relationship between specific
NP properties and resultant biological activities. In fact,
nanotoxicology literature indicates that the combination
of various physicochemical features in any type of NP
leads to different interaction with biological systems and
consequently to different toxic potentials [34, 61, 161, 162].
A deeper understanding of parameters able to alter the TiO2
NP bioactivity would support a practical approach in the
development of “safe” engineered NPs, through the choice of
a particular TiO2 form, shape, or surface functionalization
[163].
From the studies, we reviewed a great methodological
heterogeneity has emerged in terms of type of TiO2 NPs
employed, animal species treated, route of exposure, doses
applied, endpoint parameters, and techniques of measure-
ment. This causes a biased assessment of the exposure-
response relationships, prevents comparison between results
and extrapolation of definite conclusions [161]. Moreover,
results obtained employing extremely high doses of TiO2
NPs and unrealistic routes of administration, such as bolus
instillation or aspiration delivery, should be interpreted
with caution as preliminary findings to be validated under
more realistic exposure conditions [164]. However, these
preliminary data could be useful to plan future experimental
projects aimed to reveal early signs of more severe damages
induced by higher dose treatments [33, 165].
Currently, concerns regarding nanotechnology in every-
day life are emerging, particularly those relative to the
risks posed by occupational exposure, in consideration of
the increasing number of workers employed in research,
manufacture, use, and disposal of nanomaterials [163, 166].
Indeed, although not definite, the potential risk for adverse
effects in NP exposed workers demands that industry, labor,
and government concert action to a precautionary NP
risk management to protect worker health [161, 167–172].
Critical steps in reaching this target are an appropriate risk
assessment, based on epidemiologic research and exposure
evaluation, and the determination of the effective function
of risk management programs [163]. Epidemiologic studies
are essential in understanding health outcomes associated
with exposure to potentially hazardous materials. Such
studies will form the basis for quantitative risk estimations
to establish levels that protect human health. Currently,
only NIOSH has recommended a TiO2 NP exposure limit,
however, regulating TiO2 NPs appears to be a challenging
task due to the broad diversity of the NP characteristics and
their application in a wide range of sectors and products
[173]. Moreover, it has to be questioned if a generic threshold
limit, without any specification relative to the particle
characterization and the context of employment, could have
a suitable role in protecting health and safety of occupational
exposed subjects.
NP exposure in workplace settings should receive much
attention in future research. At present, the relative newness
of exposure scenarios, generally occurring in controlled
situations, the inconsistencies over the way to identify
and classify nanomaterials, questions about metrics and
practical instrumentation, and difficulty in gaining access to
workplaces mostly prevent such essential assessment [174–
180].
Additionally, as a part of the occupational exposure and
health effect evaluation, future studies should focus at iden-
tifying NP-associated biomarkers. In this regard, a deeper
knowledge about TiO2 NP mechanisms of disease, and
TiO2 NP biokinetics and potential health effects, obtained
from in vitro and in vivo experiments, respectively, could
be useful to identify indicators of early biological events
and to establish appropriate methods for their detection.
Experimentally identified biomarkers should be the focus of
subsequent validation studies aimed to define their ability
in exploring human disease endpoints [6]. Such confirmed
biological indicators of exposure and effect could be of
great relevance to the development of occupational health
surveillance strategies and also to verify the appropriateness
of collective and individual defense systems adopted during
NP manipulation.
Finally, interpreting and communicating hazard and
risk information is an integral part of the TiO2 NP risk
management that clearly requires additional research to
more thoroughly understand the toxicological interactions of
these NPs with biological systems at the molecular, cellular,
organ, and whole body level.
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